Immunological evidence for two physiological forms of protein kinase C.
about
Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino terminiThe protein kinase C-related PKC-L(eta) gene product is localized in the cell nucleusIdentification of a phorbol ester-repressible v-src-inducible geneAutophosphorylation: a salient feature of protein kinases.Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.Protein kinase C mediates platelet-derived growth factor-induced tyrosine phosphorylation of p42.Abnormal protein kinase C down regulation and reduced substrate levels in non-phorbol ester-responsive 3T3-TNR9 cells.Phosphorylation of translation initiation factor eIF-4E is induced in a ras-dependent manner during nerve growth factor-mediated PC12 cell differentiation.myc genes and their deregulation in lung cancer.Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells.Actin-based features negatively regulated by protein kinase C-epsilon.Atypical PKC-zeta and PKC-iota mediate opposing effects on MCF-7 Na+/K+ATPase activity.Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal epithelial cell line.Protein kinase C-delta mRNA is down-regulated transcriptionally and post-transcriptionally by 12-O-tetradecanoylphorbol-13-acetate.Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes.Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis.Differential potentiation of mitogen-stimulated phosphoinositide hydrolysis in protein kinase C-depleted Swiss 3T3 cells.Expression of ras oncogene leads to down-regulation of protein kinase C.Phorbol ester regulation of terminal deoxynucleotidyl transferase, proliferation, and TcR alpha in a pre-T cell line.Differences in phorbol-ester-induced down-regulation of protein kinase C between cell lines.Occurrence of immunoreactive 80 kDa and non-immunoreactive diacylglycerol kinases in different pig tissues.Down-regulation of protein kinase C is due to an increased rate of degradation.Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL).Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF.Evidence that insulin-like growth factor-1 requires protein kinase C-epsilon, PI3-kinase and mitogen-activated protein kinase pathways to protect human vascular smooth muscle cells from apoptosis.Age-dependent decrease of process formation by cultured oligodendrocytes is augmented by protein kinase C stimulation.Protein kinase C V3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation.Lung cancer cells often express high levels of protein kinase C activity.Upregulation of PKC δ- and downregulation of PKC α-mRNA and protein by a phorbol ester in human T84 cellsPossible role of Na+ influx in phorbol ester-induced down-regulation of protein kinase C in HL60 cells
P2860
Q24311546-7377637D-1DF9-4567-80F0-82A9E159A5B8Q24606883-82EABD86-F213-45C7-B377-FA424DB3C341Q33837057-6F70590D-B66A-4479-B2DE-3B8512B1D343Q34323982-0123C3AA-6BF8-4F7E-BFF6-A48C30F79883Q35787010-33978129-3B5A-4292-BBCF-DE7CD0C84C01Q36218395-E73F79F3-24F5-453D-81ED-755B9A2BA060Q36708401-E78A7821-5C40-4610-9B97-3D998D15B62CQ36963443-610B188D-2F06-4AE1-8414-DE1570D3BF9EQ37910110-C0610E5A-6281-4F78-A6B3-E049C9CFC278Q38347857-517B2FFB-635C-4C16-A157-A7AF489AD73FQ39771355-FD9A611D-BAA7-4640-A0C7-EA45D5893A8CQ40423999-2B09E949-2174-44C7-8486-1BC4CB22FAEEQ40911707-6FBF0976-03C7-446E-AA1F-4169DEEEE4B2Q41186166-2C5BB668-1837-4B5E-8741-8C4E5C2A495FQ41233268-BA73B564-D8FA-4AD6-9A25-D5702D2B0B49Q41360988-4E4547FE-EA6C-4567-A2E3-054B421BACEAQ41723198-62A07153-F8E4-42C6-A090-8D3BBECA4059Q41730766-B8736AAF-0F63-4337-8BBD-94185B835BE7Q41742653-04C22E9F-A7DB-41AA-8754-F52F103E5C68Q41847388-BFD3492E-DC19-489E-AAF2-BE91ED4790E0Q42144348-6A77CA37-7F92-4419-9AD5-FA3DD05ED441Q42856236-771A0FE7-74B5-484E-B5A3-E0595803C97AQ43223918-4B4705B7-702A-47CC-8BCB-D1E5967AD610Q46769898-581FADD6-B53C-497E-9F52-20F0A6417B9CQ46787729-121A29CC-9666-4F4F-9D9E-722564D5C77DQ48729940-74A76299-D7C1-4C61-986E-56668AE6BFA8Q54199945-0D5F3917-B79D-45CB-B09F-703418163F6FQ55339837-BB50517C-9486-4D2F-A8BD-9969F000834EQ56987787-1009C403-B0A8-4DA6-82B0-9665300485A4Q58034573-8D58F69B-622D-4108-BC84-78ECA0263917
P2860
Immunological evidence for two physiological forms of protein kinase C.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Immunological evidence for two physiological forms of protein kinase C.
@en
type
label
Immunological evidence for two physiological forms of protein kinase C.
@en
prefLabel
Immunological evidence for two physiological forms of protein kinase C.
@en
P2860
P356
P1476
Immunological evidence for two physiological forms of protein kinase C.
@en
P2093
J R Woodgett
P2860
P356
10.1128/MCB.7.1.85
P407
P577
1987-01-01T00:00:00Z